A significant trading signal occurred for Regeneron Pharma stock at a price of $501.83, after which REGN rose up to 3.2%.

U.S. stock markets were muted and closed mixed on Monday. Market participants’ sentiments were subdued following the reinitiation of trade talks between the United States and China. The Nasdaq ...

Regeneron Pharmaceuticals saw a downgrade from Wells Fargo, slicing its stock rating from "overweight" to "equal weight" and ...

Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while ...

SINGAPORE] Amid a flurry of delistings from the Singapore Exchange (SGX), one more privatisation offer – especially that for ...

Citigroup has reduced Regeneron Pharmaceuticals’ price target from $700 to $650, though it still maintains a “buy” rating.

In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...

Guggenheim maintains a “Buy” rating for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) despite challenges, including the delayed regulatory submissions of Itepekimab. The delay in Itepekimab’s approval ...

The S&P 500 slipped less than 0.1% on Friday, May 30, 2025, as President Trump rekindled his tough rhetoric on China and a ...

Key Takeaways U.S. equities were lower at midday on concerns about where the U.S.-China trade war is heading.A late-stage ...

est de retour pour une seconde année en tant qu’organisation de prix spéciaux à la Foire internationale des sciences et de l’ingénierie de Regeneron (Regeneron ISEF) à Columbus ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.